Wageningen UR Teams with Luminex to Develop Multiplex Screening Solutions for Agro Biotechnology Market

  
    
  
  
    
      Wageningen University and Research Centre, a leading organization in the 
      field of life sciences and natural resources with focus on healthy food 
      production, biodiversity, and sustainable production chains, and Luminex 
      Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed 
      solutions, today announced that they have signed a licensing agreement 
      to provide Wageningen UR access to Luminex's xMAP® 
      technology and the Luminex Bioscience Group’s 
      assay development capabilities.
    
    
      Under the terms of the agreement, Wageningen UR will utilize Luminex's 
      xMAP technology in selected areas of Agro Biotechnology. Focus 
      application areas are expected to include plant pathogen detection, 
      epidemiology, food safety, and marker assisted plant and animal breeding 
      programs. The demand for fast multiplex testing, or performing multiple 
      tests on a single sample, continues to accelerate in Agro Biotechnology 
      markets.
    
    
      "Providing our customers with access to a proven multiplexing solution 
      is essential to assist specific research and development needs and for 
      long-term growth," said Raoul Bino, Professor Plant Metabolomics and 
      director of the Plant Sciences Group of Wageningen UR. "We have selected 
      Luminex's xMAP technology as a recognized industry benchmark in life 
      science research and multiplex diagnostics applications. We look forward 
      to working closely and collaboratively with Luminex to benefit our 
      respective customers."
    
    
      Douglas Bryant, executive vice president and chief operating officer at 
      Luminex Corporation, commented, "This agreement with Wageningen UR is a 
      prime example of Luminex's growing emphasis on establishing long-term 
      partnerships and collaborations with market leaders in segments of 
      strategic significance to Luminex. In this relationship with Wageningen 
      UR, we are not only providing new markets and customers with access to 
      the Luminex xMAP technology, we also are partnering with a recognized 
      knowledge organization with significant experience in Agro Biotechnology 
      markets. We are excited to have Wageningen UR on board, and look forward 
      to pursuing additional collaborative opportunities with them in the 
      future."
    
    
      About Luminex Corporation
    
    
      Luminex Corporation develops, manufactures and markets proprietary 
      biological testing technologies with applications throughout the 
      diagnostic and life sciences industries. The Company's xMAP® 
      multiplex solutions include an open-architecture, multi-analyte 
      technology platform that delivers fast, accurate and cost-effective 
      bioassay results to markets as diverse as pharmaceutical drug discovery, 
      clinical diagnostics and biomedical research, including the genomics and 
      proteomics markets. The Company's xMAP technology is sold worldwide and 
      is already in use in leading clinical laboratories as well as major 
      pharmaceutical, diagnostic and biotechnology companies. Further 
      information on Luminex Corporation or xMAP can be obtained at www.luminexcorp.com.
    
    
      About Wageningen UR
    
    
      Wageningen UR is a collaboration between Wageningen University, Van Hall 
      Larenstein School of Higher Professional Education and the specialised 
      former research institutes (DLO) from the Dutch Ministry of Agriculture. 
      This combination of knowledge and experience enables Wageningen UR with 
      its 5.600 staff and more than 8.500 students to contribute actively to 
      solving scientific, social and commercial problems in the field of life 
      sciences and natural resources. Wageningen UR approaches these national 
      and international issues from the perspectives of various disciplines, 
      with an integrated approach and in close collaboration with governments, 
      companies, stakeholder organisations, citizens, and other 
      knowledge institutions. We pay attention to the balance between three 
      priorities in society: economics, culture and nature.